MedPath

Medroxyprogesterone

MedroxyPROGESTERone Acetate Tablets USP

Approved
Approval ID

1403a9a9-c04a-432f-8819-4850f779312e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 9, 2022

Manufacturers
FDA

PharmPak, Inc.

DUNS: 175493840

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

MEDROXYPROGESTERONE

PRODUCT DETAILS

NDC Product Code54348-805
Application NumberANDA040159
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateOctober 9, 2022
Generic NameMEDROXYPROGESTERONE

INGREDIENTS (7)

CROSPOVIDONEInactive
Code: 2S7830E561
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
METHYLCELLULOSE (15 CPS)Inactive
Code: NPU9M2E6L8
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
MEDROXYPROGESTERONE ACETATEActive
Quantity: 10 mg in 1 1
Code: C2QI4IOI2G
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Medroxyprogesterone - FDA Drug Approval Details